Lower Progression Rate of End-Stage Renal Disease in Patients with Peripheral Arterial Disease Using Statins or Angiotensin-Converting Enzyme Inhibitors-Reference-Cited by-同舟云学术

Lower Progression Rate of End-Stage Renal Disease in Patients with Peripheral Arterial Disease Using Statins or Angiotensin-Converting Enzyme Inhibitors

Published:2007-05-02 Issue:6 Volume:18 Page:1872-1879
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Feringa Harm H.H.,Karagiannis Stefanos E.,Chonchol Michel,Vidakovic Radosav,Noordzij Peter G.,Elhendy Abdou,van Domburg Ron T.,Welten Gijs,Schouten Olaf,Bax Jeroen J.,Berl Tomas,Poldermans Don

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference37 articles.

1. ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)

2. The Ankle-Brachial Index in the Elderly and Risk of Stroke, Coronary Disease, and Death

3. The prevalence of peripheral arterial disease in a defined population.

4. Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice

5. Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral artery disease and risk of kidney outcomes: The Atherosclerosis Risk in Communities (ARIC) study;Atherosclerosis;2024-10

2. Protective Effects of Statins on Limb and Cardiovascular Outcomes in Patients with Peripheral Artery Disease and End-Stage Renal Disease;ACTA CARDIOL SIN;2023

3. Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients;BMC Nephrology;2017-11-29

4. The effect of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on mortality in patients with chronic kidney disease: a meta-analysis of observational studies;Pharmacoepidemiology and Drug Safety;2016-01-19

5. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients;Cochrane Database of Systematic Reviews;2014-12-09